Such surface-exposed calreticulin induces the uptake of dying cancer cells by CD11c-positive myeloid dendritic cells, leading to tumor antigen presentation to T-cells and concomitant clonal T-cell expansion. The gene discussed is CALR; the disease is neoplasm.